| Sonoma Bio Launches With $40M to Take Cell Therapy Beyond Cancer | Frank Vinluan | 02/06/20 | San Francisco |
| Bayer Buys Out BlueRock, Betting at Least $240M More on Cell Therapy Work | Ben Fidler | 08/08/19 | Boston |
| Redox Wrangles $33M to Become Healthcare’s Go-To Data Integrator | Jeff Bauter Engel | 04/18/19 | Wisconsin |
| AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results | Ben Fidler | 04/03/19 | National |
| Bio-JPM Roundup: Lilly Buys Loxo, Sage’s Stock Soars, ALS Cash & More | Frank Vinluan | 01/07/19 | National |
| Tiburio Launches from Cydan with $31M to Tackle Pituitary Tumors | Frank Vinluan | 01/03/19 | Boston |
| NY’s Research Institutions Must Keep Working Together in ‘19 | Orin Herskowitz | 12/31/18 | New York |
| ImageMoverMD Nabs Another $1.6M For Secure Patient Photo-Sharing App | Jeff Buchanan | 09/28/18 | Wisconsin |
| Y-mAbs Upsizes IPO, Gets $96M to Test Two Pediatric Cancer Drugs | Frank Vinluan | 09/21/18 | New York |
| Y-mAbs Plans IPO to Advance Two Pediatric Cancer Drugs to the FDA | Frank Vinluan | 08/27/18 | New York |
| Gregor Diagnostics Raises $900K to Develop New Prostate Cancer Test | Jeff Buchanan | 07/10/18 | Wisconsin |
| Drugs OK’d To Hit Tumor Genes Still a Basket of One. Are More Coming? | Alex Lash | 05/31/18 | National |
| CMS Starts to Cover Broad Cancer DNA Tests, Boosting Foundation, Thermo | Ben Fidler | 03/19/18 | Boston |
| Roche Bets $1.7B More on Precision Oncology With Ignyta Deal | Ben Fidler | 12/22/17 | San Diego |
| Will Foundation’s FDA, CMS Nod Help Cancer DNA Tests Break Through? | Ben Fidler | 12/01/17 | Boston |
| UT Nominates MD Anderson Alum Peter Pisters to Replace DePinho | Angela Shah | 08/25/17 | Texas |
| Precision Steps: Can Loxo Drug Help Broaden Use of Cancer DNA Tests? | Ben Fidler | 06/03/17 | National |
| Varmus, Sato on Steering De Blasio’s $500M Plan to Grow NY Biotech | Ben Fidler | 12/30/16 | New York |
| Flatiron, Foundation Med Link Records of 20,000 Cancer Patients | Alex Lash | 11/03/16 | New York |
| All In One Place: A New Immuno-Oncology Trial Resource | Alex Lash | 10/19/16 | National |
| Bio Roundup: Cancer Wishes and Shopping Lists, Allergan Pricing & More | Alex Lash | 09/09/16 | National |
| Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches | Alex Lash | 09/07/16 | National |
| After Three Deaths, FDA Halts Juno’s Leading CAR-T Trial | David Holley | 07/07/16 | Seattle |
| Rgenix Raises $33M, Preps Cancer Trial For Drug Shelved By GSK | Alex Lash | 06/15/16 | New York |
| East Coast Biotech Roundup: Intellia, What’s Hot, Cydan, Fog & More | Ben Fidler | 04/14/16 | Boston |
| New York City: En Route to a Bio Cluster | Louis Levy and Vicki Sato | 02/29/16 | New York |
| Rockefeller’s Tessier-Lavigne Heads Back to the Bay to Run Stanford | Ben Fidler | 02/04/16 | New York |
| Blood Simple? Grail’s Cancer Screening Quest Faces Tough Questions | Alex Lash | 02/04/16 | National |
| Led By Biotech Stars, ORIC Nabs $53M To Fight Drug-Resistant Cancer | Alex Lash | 12/02/15 | San Francisco |
| Cancer Vaccines Back in Vogue as VCs Put $102M Into Gritstone Oncology | Ben Fidler | 10/20/15 | San Francisco |
